Net Cash Provided by (Used in) Operating Activities |
-16.1K |
USD |
|
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
|
Q2 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
12M |
shares |
|
Q2 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
109K |
USD |
+421% |
Q2 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
5.63K |
USD |
|
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Gross |
5.63K |
USD |
|
Q2 2024 |
Q3 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
983 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
5.63K |
USD |
|
Q2 2024 |
Q3 2024 |
Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Current Income Tax Expense (Benefit) |
469 |
USD |
|
Q4 2023 |
Q1 2024 |
Additional Paid in Capital |
139K |
USD |
|
Q2 2024 |
Q3 2024 |
Current State and Local Tax Expense (Benefit) |
208 |
USD |
|
Q4 2023 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
261 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
Q3 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q1 2024 |